4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001635088-26-000120
President & Immunovant CEO sold 200,000 shares at $36.59 ($7,318,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Venker Eric President & Immunovant CEO | 2026-10-28 | Sale 10b5-1 | −200,000 | $36.59 | $7,318,000 | 1,199,154 | D: show line 1 in the form |
| Open-market sales · 200,000 sh · avg $36.59 · $7,318,000 | |||||||
Loading xslF345X06/wk-form4_1793399338.xml…